Biotech Stocks

Sorrento (SRNE) Stock Has Over 700% Upside Potential, Says Analyst

Can you feel the ground moving beneath your feet? Shares of Sorrento Therapeutics (SRNE) skyrocketed 70% today after the small drug maker were …

3 ‘Strong Buy’ Biotech Stocks to Watch After Stifel Healthcare Conference

Are you prone to sudden surges of joy, abruptly followed by sinking bouts of misery? Do you react disproportionately to good or bad …

These 3 “Strong Buy” Healthcare Stocks Have 40% Upside — Or More, Says Cowen

The world’s population is getting older, rapidly. According to the United Nations, the fastest-growing age group across the world is adults aged 65 …

Hedge Fund Innovator Joseph Edelman Doubles Down on These 3 Biotech Stocks

More than 500 biotech companies operate in the US, doing their part to make it the world’s hub for innovation. Only about 20 …

Oppenheimer Sees Doom and Gloom in Amarin (AMRN) Stock

Buoyed by optimism over the label expansion of Amarin’s (AMRN) flagship drug, Vascepa, the fish oil drug maker’s stock has run off to …

How Much Higher Can Amarin (AMRN) Stock Go Following FDA Approval?

Amarin (AMRN) investors received a nice gift going into the weekend, after shares of the biopharma increased by almost 12% on Friday. The …

3 “Strong Buy” Biotech Stocks That Recently Went Public

This year has seen more than its share of successful IPOs – and some giant flops. The extremes should have been expected, in …

There’s an Opportunity Brewing in Amarin (AMRN) Stock Ahead of Vascepa’s AdCom, Says Analyst

Get in here before November 14, 2019. On this date an FDA Advisory Committee (AdCom) is scheduled to meet to discuss Amarin’s (AMRN) …

3 Hot Biotech Stocks With 100% Street Support

For more risk-tolerant investors, biotechs are screaming buys. This space is consistently on the Street’s radar as a single catalyst such as a …

Agile (AGRX) Stock Surges Over 370%, What’s Next?

Agile therapeutics (AGRX) has had a, shall we say, crazy week in the market. On Monday, October 28, its share price was sent …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts